TrialThe New England journal of medicine2014
Ibrutinib versus ofatumumab in previously treated chronic lymphoid leukemia.
John C Byrd et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
773 papers cite itlatest 60 shown
this paperpooled ittrialcites it